|
|
|
|
Management:
|
|
Kwan
H. Lee, M.D., Ph.D. |
Co-Founder, President,
CEO |
| |
Untitled Document
Dr. Lee is
a co-founder of TissueGene and serves
as the Company's President and Chief Executive Officer. He is trained as an orthopedic
surgeon with approximately 20 years of experience.
He obtained his M.D. from the prestigious Seoul National University in Korea in
1982 and a Ph. D. in orthopedic sciences from the same university in 1993. He
also has been a guest researcher at the U.S. National Institutes of Health, conducting
key studies involving the therapeutic use of TGF-bs. Dr. Lee is well-known as
a world-wide leader in the field of orthopedic medicine.
He has served as the Director of the Clinical Research Center of Inha University
Hospital in Korea, as well as a professor there. He is a member of the Gene Therapy
Committee of the Korean FDA, which has provided him unique experience in understanding
the drug evaluation and approval process in connection with genetic therapies
such as TissueGene's own cell-mediated
technology.
|
| |
|
|
